Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 72Leukemia 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Leukemia, Myelomonocytic, Acute 24Leukemia, Monocytic, Acute 22Leukemia, Erythroblastic, Acute 22Leukemia, Megakaryoblastic, Acute 20Congenital Abnormalities 18Myelodysplastic Syndromes 10Lymphoma 10Anemia, Refractory, with Excess of Blasts 10Burkitt Lymphoma 8Leukemia, Eosinophilic, Acute 7Leukemia, Myelomonocytic, Chronic 6Leukemia, Basophilic, Acute 6Myeloproliferative Disorders 5Leukemia, Biphenotypic, Acute 5Leukemia, Promyelocytic, Acute 4Dendritic Cell Sarcoma, Interdigitating 4Thrombocytopenia 3Neoplasm, Residual 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Recurrence 2Philadelphia Chromosome 2Neutropenia 2Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Dexamethasone 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Blood Specimen Collection 4Surveys and Questionnaires 3Prednisone 3Melphalan 3Lenalidomide 3Biopsy, Fine-Needle 3fluciclovine F-18 2carfilzomib 2Positron-Emission Tomography 2Mammography 2Injections 2Immunohistochemistry 2Gemcitabine 2Cytarabine 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2weifuchun 1vistusertib 1venetoclax 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1ofatumumab 1obinutuzumab 1lortalamine 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Disease × Daunorubicin × Clear all
NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Jazz Pharmaceuticals

Phase 2 Completed
126 enrolled 12 charts
Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡